Contraceptive, injectable

Injectable Contraceptives. Injections of contraceptive dmgs must be sufficiendy spaced to make the approach attractive to the user. The average contraceptive user is not willing to endure daily injections or injection intervals of one or two weeks the minimum acceptable injection interval has been found to be at least four weeks. [Pg.117]

Long-acting activity of injectable contraceptives can be accompHshed via a number of different approaches. Steroid activity can be extended over a... [Pg.117]

Long-term injectable contraceptive administered IM every 3 months. The injection is given only during the first 5 days after the onset of a normal menstrual period, within 5 days postpartum if not breastfeeding, or at 6 weeks postpartum. [Pg.554]

Depo-Provera An Injectable Contraceptive (Last updated 2003, March). American Academy of Family Physicians. Retrieved April 8, 2004 from http //www.familydoctor.org/handouts/043.html... [Pg.47]

Prevention of pregnancy It is a long-term injectable contraceptive in women when administered at 3-month intervals. [Pg.226]

Fraser IS. Vaginal bleeding patterns in women using once-a-month injectable contraceptives. Contraception 1994 49(4) 399 120. [Pg.212]

The adverse effects of norethisterone enantate when used as a 2-monthly injectable contraceptive have been compared in various populations with those of depot medroxyprogesterone acetate and were found to be closely similar (5,6). [Pg.253]

Salem HT, Salah M, Aly MY, Thabet AI, Shaaban MM, Fathalla MF. Acceptability of injectable contraceptives in Assiut, Egypt. Contraception 1988 38(6) 697-710. [Pg.253]

Howard G, Blair M, Fotherby K, Elder MG, Bye P. Seven years clinical experience of the injectable contraceptive, norethisterone enanthate. Br J Fam Plann 1985 11 9. [Pg.253]

Chowdhury TA. A clinical study on injectable contraceptive Noristerat. Bangladesh Med J 1985 14(2-3) 28-35. [Pg.253]

Kaunitz AM. Long-acting injectable contraception with depot medroxyprogesterone acetate. Am J Obstet Gynecol 1994 170(5 Pt 2) 1543-9. [Pg.284]

La Vecchia C. Depot-medroxyprogesterone acetate, other injectable contraceptives, and cervical neoplasia. Contraception 1994 49(3) 223-30. [Pg.284]

Fotherby K, Howard G. Return of fertility in women discontinuing injectable contraceptives. J Obstet Gynaecol 1986 6(Suppl 2) S110-5. [Pg.284]

L.-X, Jiang, Z. J. Wang, and S. A. Matlin, HPLC analysis of injectable contraceptive preparation containing norethisterone en-anthate and estradiol valerate, J. Liquid Chromatogr., 73 3473... [Pg.416]

Tagy A, Saker M, Moussa A, Kolgah A (2001) The effect of low dose combined oral contraceptive pills versus injectable contraceptive (Depot Provera) on liver function tests of women with compensated bilharzial liver fibrosis. Contraception 64 173-176. [Pg.292]

Lunelle. Lunelle is a newer injectable contraceptive formulation that combines the effects of a progestin, medroxy-... [Pg.793]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...